In one such attempt, Huang and colleagues [192] treated A549 NSCLC cells with ERRα inverse agonist XCT-790 and observed the ERRα involvement in epithelial–mesenchymal transition (EMT). Here, ESRRA is linked to non-small cell lung carcinoma.